4th Quarter - Report
MEDIMMUNE, LLC. for MEDIMMUNE LLC
Firm
Client
Income
—
Expenses
$180,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 5629 Pathway for Biosimilars Act: All Provisions SCHIP Reauthorization: Premature Access to Care Increase to Fee-for Service Medicaid Rebate and Expansion to Managed Medicaid Issues Impacting School-based Influenza Projects
Foreign entity interest: As the ultimate parent of MedImmune, LLC., Astra Zenenca PLC, has interests in the issues lobbied.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VANESSA PROCTER | — |
| BRIAN M ROSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.